Average Co-Inventor Count = 5.34
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Kali-chemie Pharma Gmbh (11 from 92 patents)
2. Solvay Pharmaceuticals, Gmbh (7 from 75 patents)
3. Abbvie Inc. (3 from 822 patents)
4. Abbott Products Gmbh (3 from 17 patents)
22 patents:
1. 9567355 - Hepatitis C inhibitors and uses thereof
2. 9453007 - Hepatitis C inhibitors and uses thereof
3. 9173887 - Hepatitis C inhibitors and uses thereof
4. 8288367 - Substituted estratriene derivatives as 17BETA HSD inhibitors
5. 8080540 - Therapeutically active triazoles and their use
6. 7772225 - N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
7. 7592344 - NK1 and NK2-antagonists and compositions and methods of using the same
8. 7547708 - N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof
9. 6602880 - 3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia
10. 6407106 - N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity
11. 5843948 - Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives,
12. 5635511 - Treatment of heart rhythm disorders by administration of
13. 5576327 - Treatment of heart rhythym disorders by administration of
14. 5532251 - Method of treating cardiac arrhythmia with 3-benzoyl-3,
15. 5324732 - Crystalline fumaric acid salts of 9,9-alkylene-3,7-diazabicyclononane